Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-2,785
Closed -$235K – 1080
2023
Q3
$235K Buy
2,785
+223
+9% +$20.1K ﹤0.01% 950
2023
Q2
$253K Buy
2,562
+94
+4% +$8.84K ﹤0.01% 945
2023
Q1
$237K Sell
2,468
-115
-4% -$10.6K ﹤0.01% 932
2022
Q4
$235K Sell
2,583
-18,888
-88% -$1.61M ﹤0.01% 893
2022
Q3
$1.71M Sell
21,471
-18,481
-46% -$1.57M 0.01% 379
2022
Q2
$3.33M Buy
39,952
+2,309
+6% +$190K 0.03% 299
2022
Q1
$3.1M Sell
37,643
-3,269
-8% -$256K 0.02% 328
2021
Q4
$3.06M Buy
40,912
+18,503
+83% +$1.39M 0.02% 334
2021
Q3
$1.7M Buy
22,409
+19,433
+653% +$1.5M 0.01% 418
2021
Q2
$230K Buy
+2,976
New +$230K ﹤0.01% 873

Other funds holding DOX

Davenport & Co's DOX Position: Q4 2023 in Review

Davenport & Co sold out of Amdocs (DOX) in Q4 2023, closing a stake of 2,785 shares — an estimated $235K sold.

Davenport & Co first reported a position in DOX in Q2 2021 and held it in 10 quarters. The position peaked at $3.33M in Q2 2022. 510 funds tracked by Wall St. Rank hold DOX as of Q4 2023.

  • Davenport & Co reported no remaining Amdocs position as of Q4 2023 after selling out during the quarter.
  • Davenport & Co sold 2,785 Amdocs shares in Q4 2023, an estimated $235K.
  • Davenport & Co first reported a position in Amdocs in Q2 2021 and held it in 10 quarters.
  • Davenport & Co's Amdocs position peaked at $3.33M in Q2 2022.
  • 510 funds tracked by Wall St. Rank held Amdocs as of Q4 2023.

Based on Davenport & Co's 13F filing for Q4 2023, filed 23 Jan 2024.